Plain-English translation of NCT07798700 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects blood samples from people diagnosed with neurodegenerative diseases—conditions that gradually affect the brain and nervous system—as well as from their family members. By studying these blood samples, researchers aim to understand the genetic and molecular causes of diseases like Alzheimer's, Parkinson's, ALS, and frontotemporal dementia. The goal is to build a resource that will help scientists develop better treatments and understanding of these conditions.
Many brain diseases run in families, but we still don't fully understand why some people develop them and others don't. By collecting and studying blood samples from affected individuals and their relatives, researchers can identify genetic risk factors and biological markers that might lead to better diagnosis, prevention, and treatment in the future.
You likely qualify if…
You likely don't qualify if…
As a participant, you would provide a blood sample and share your family history and basic demographic information with the researchers. This is a non-invasive process that typically takes place during a single visit. Your blood sample will be stored and used for genetic and molecular research to help advance understanding of neurodegenerative diseases, and researchers may contact you in the future for additional information or samples if you agree.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
United States